Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis

OBJECTIVE: To evaluate the efficacy and safety of antiviral antibody therapies and blood products for the treatment of novel coronavirus disease 2019 (covid-19). DESIGN: Living systematic review and network meta-analysis, with pairwise meta-analysis for outcomes with insufficient data. DATA SOURCES:...

Descripción completa

Detalles Bibliográficos
Autores principales: Siemieniuk, Reed AC, Bartoszko, Jessica J, Díaz Martinez, Juan Pablo, Kum, Elena, Qasim, Anila, Zeraatkar, Dena, Izcovich, Ariel, Mangala, Sophia, Ge, Long, Han, Mi Ah, Agoritsas, Thomas, Arnold, Donald, Ávila, Camila, Chu, Derek K, Couban, Rachel, Cusano, Ellen, Darzi, Andrea J, Devji, Tahira, Foroutan, Farid, Ghadimi, Maryam, Khamis, Assem, Lamontagne, Francois, Loeb, Mark, Miroshnychenko, Anna, Motaghi, Sharhzad, Murthy, Srinivas, Mustafa, Reem A, Rada, Gabriel, Rochwerg, Bram, Switzer, Charlotte, Vandvik, Per O, Vernooij, Robin WM, Wang, Ying, Yao, Liang, Guyatt, Gordon H, Brignardello-Petersen, Romina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459162/
https://www.ncbi.nlm.nih.gov/pubmed/34556486
http://dx.doi.org/10.1136/bmj.n2231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459162/
https://www.ncbi.nlm.nih.gov/pubmed/34556486
http://dx.doi.org/10.1136/bmj.n2231

Ejemplares similares